TrialAddiction (Abingdon, England)2025

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data.

Sara Lodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.